John Pagel, MD PhD, is the Senior Vice President of Clinical Development and Global Head of Medical Oncology and Hematology at Eli Lilly and Company. Previously, they served as the Chief of Hematologic Malignancies and Director of Stem Cell Transplantation at the Swedish Cancer Institute from 2014 to 2021. From 1999 to 2014, they held various academic positions at the Fred Hutchinson Cancer Research Center and the University of Washington.
This person is not in any teams
This person is not in any offices